BackSAB Biotherapeutics- Warrants (25/07/2027) Overview

SAB Biotherapeutics- Warrants (25/07/2027) Common Stock

Latest common stock for SABSW: $8K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$8000.00
↑ 754.70% YoYΔ $7064.00 vs prior year quarter

Peer trimmed avg / median

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Common Stock History

Loading

SAB Biotherapeutics- Warrants (25/07/2027) vs. peers: Common Stock Comparison

Loading

SAB Biotherapeutics- Warrants (25/07/2027) Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

SAB Biotherapeutics- Warrants (25/07/2027) (SABSW) FAQ

As of the most recent data (June 2026), SABSW shows a common stock of $8K. That compares with $940 in the prior-year period — up 754.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SABSW's common stock is now $8K (was $940) — a 754.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether SAB Biotherapeutics- Warrants (25/07/2027) is outperforming or lagging.

Tracking SABSW's common stock over time shows whether SAB Biotherapeutics- Warrants (25/07/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $8K That compares with $940 in the prior-year period — up 754.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has SAB Biotherapeutics- Warrants (25/07/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $8K) with ownership activity and broader fundamentals.